Highlights of Ophthalmology

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Related articles

VOLUME 46 , ISSUE 5ENG ( Oct-2018, 2018 ) > List of Articles

Steroid Use in Infectious Keratitis

J. Heriberto Dávila Alquisiras, Francisco Beltrán Díaz de la Vega, Manuel Garza León

Citation Information : Alquisiras JH, Vega FB, León MG. Steroid Use in Infectious Keratitis. 2018; 46 (5ENG):10-19.

DOI: 10.5005/highlights-46-5-10

Published Online: 01-01-2021

Copyright Statement:  Copyright © 2018; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

PDF Share
  1. Hernandez-Camarena JC, Graue-Hernandez EO, Ortiz-Casas M, Ramirez-Miranda A, Navas A, Pedro-Aguilar L, Lopez-Espinosa NL, Gaona- Juarez C, Bautista-Hernandez LA, Bautista-de Lucio VM. Trends in Microbiological and Antibiotic Sensitivity Patterns in Infectious Keratitis: 10-Year Experience in Mexico City. Cornea 2015; 34: 778-785
  2. Parra-Rodríguez DS, García-Carmona KP, Vázquez-Maya L, Bonifaz A. Incidencia de úlceras corneales microbianas en el Servicio de Oftalmología del Hospital General de México Dr. Eduardo Liceaga. Revista Mexicana de Oftalmología 2016; 90: 209-214
  3. Ranjini CY, Waddepally VV. Microbial Profile of Corneal Ulcers in a Tertiary Care Hospital in South India. Journal of ophthalmic & vision research 2016; 11: 363-367
  4. Tam ALC, Cote E, Saldanha M, Lichtinger A, Slomovic AR. Bacterial Keratitis in Toronto: A 16-Year Review of the Microorganisms Isolated and the Resistance Patterns Observed. Cornea 2017; 36: 1528-1534
  5. Termote K, Joe AW, Butler AL, McCarthy M, Blondeau JM, Iovieno A, Holland SP, Yeung SN. Epidemiology of bacterial corneal ulcers at tertiary centres in Vancouver, B.C. Canadian journal of ophthalmology Journal canadien d'ophtalmologie 2018; 53: 330-336
  6. Prokosch V, Gatzioufas Z, Thanos S, Stupp T. Microbiological findings and predisposing risk factors in corneal ulcers. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2012; 250: 369- 374
  7. Sauer A, Meyer N, Bourcier T. Risk Factors for Contact Lens-Related Microbial Keratitis: A Case-Control Multicenter Study. Eye & contact lens 2016; 42: 158-162
  8. Lim CH, Carnt NA, Farook M, Lam J, Tan DT, Mehta JS, Stapleton F. Risk factors for contact lens-related microbial keratitis in Singapore. Eye (London, England) 2016; 30: 447-455
  9. Schallhorn JM, Schallhorn SC, Hettinger K, Hannan S. Infectious keratitis after laser vision correction: Incidence and risk factors. Journal of cataract and refractive surgery 2017; 43: 473-479
  10. Moorthy S, Graue E, Jhanji V, Constantinou M, Vajpayee RB. Microbial keratitis after penetrating keratoplasty: impact of sutures. American journal of ophthalmology 2011; 152: 189-194.e182
  11. Sun JP, Chen WL, Huang JY, Hou YC, Wang IJ, Hu FR. Microbial Keratitis After Penetrating Keratoplasty. American journal of ophthalmology 2017; 178: 150-156
  12. Ansari AS, de Lusignan S, Arrowsmith B, Hinton W, Munro N, McGovern A. Association Between Diabetes, Level of Glycemic Control, and Eye Infection: A Cohort Study. Diabetes care 2017; 40: e30-e31
  13. Carnt N, Robaei D, Minassian DC, Dart JKG. Acanthamoeba keratitis in 194. patients: risk factors for bad outcomes and severe inflammatory complications. The British journal of ophthalmology 2018
  14. Henry CR, Flynn HW, Jr., Miller D, Forster RK, Alfonso EC. Infectious keratitis progressing to endophthalmitis: a 15-year study of microbiology, associated factors, and clinical outcomes. Ophthalmology 2012; 119: 2443-2449
  15. Ni N, Srinivasan M, McLeod SD, Acharya NR, Lietman TM, Rose-Nussbaumer J. Use of adjunctive topical corticosteroids in bacterial keratitis. Current opinion in ophthalmology 2016; 27: 353-357
  16. Palioura S, Henry CR, Amescua G, Alfonso EC. Role of steroids in the treatment of bacterial keratitis. Clinical ophthalmology (Auckland, NZ) 2016; 10: 179-186
  17. Maharana PK, Sahay P, Sujeeth M, Singhal D, Rathi A, Titiyal JS, Sharma N. Microbial Keratitis After Accelerated Corneal Collagen Cross-Linking in Keratoconus. Cornea 2018; 37: 162-167
  18. Tabatabaei SA, Soleimani M, Mirghorbani M, Tafti ZF, Rahimi F. Microbial keratitis following intracorneal ring implantation. Clinical & experimental optometry 2018
  19. Jin H, Parker WT, Law NW, Clarke CL, Gisseman JD, Pflugfelder SC, Wang L, Al-Mohtaseb ZN. Evolving risk factors and antibiotic sensitivity patterns for microbial keratitis at a large county hospital. The British journal of ophthalmology 2017; 101: 1483-1487
  20. Schaftenaar E, Peters RP, Baarsma GS, Meenken C, Khosa NS, Getu S, McIntyre JA, Osterhaus AD, Verjans GM. Clinical and corneal microbial profile of infectious keratitis in a high HIV prevalence setting in rural South Africa. European journal of clinical microbiology & infectious diseases: official publication of the European Society of Clinical Microbiology 2016; 35: 1403-1409
  21. Miedziak AI, Miller MR, Rapuano CJ, Laibson PR, Cohen EJ. Risk factors in microbial keratitis leading to penetrating keratoplasty. Ophthalmology 1999; 106: 1166-1170; discussion 1171
  22. Hindman HB, Patel SB, Jun AS. Rationale for adjunctive topical corticosteroids in bacterial keratitis. Archives of ophthalmology (Chicago, Ill: 1960) 2009; 127: 97-102
  23. Herretes S, Wang X, Reyes JM. Topical corticosteroids as adjunctive therapy for bacterial keratitis. The Cochrane database of systematic reviews 2014: Cd005430
  24. Carmichael TR, Gelfand Y, Welsh NH. Topical steroids in the treatment of central and paracentral corneal ulcers. The British journal of ophthalmology 1990; 74: 528-531
  25. Acharya NR, Srinivasan M, Mascarenhas J, Ravindran M, Rajaraman R, Zegans M, McLeod S, Lietman TM. The steroid controversy in bacterial keratitis. Archives of ophthalmology (Chicago, Ill: 1960) 2009; 127: 1231
  26. Lalitha P, Srinivasan M, Rajaraman R, Ravindran M, Mascarenhas J, Priya JL, Sy A, Oldenburg CE, Ray KJ, Zegans ME, McLeod SD, Lietman TM, Acharya NR. Nocardia keratitis: clinical course and effect of corticosteroids. American journal of ophthalmology 2012; 154: 934-939. e931
  27. Ray KJ, Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Glidden DV, Oldenburg CE, Sun CQ, Zegans ME, McLeod SD, Acharya NR, Lietman TM. Early addition of topical corticosteroids in the treatment of bacterial keratitis. JAMA ophthalmology 2014; 132: 737-741
  28. Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Lalitha P, O'Brien KS, Glidden DV, Ray KJ, Oldenburg CE, Zegans ME, Whitcher JP, McLeod SD, Porco TC, Lietman TM, Acharya NR. The steroids for corneal ulcers trial (SCUT): secondary 12-month clinical outcomes of a randomized controlled trial. American journal of ophthalmology 2014; 157: 327-333.e323
  29. Blair J, Hodge W, Al-Ghamdi S, Balabanian R, Lowcock B, Pan YI, Sherif H, Al Mahmoud T, Fergusson D, Slomovic A. Comparison of antibioticonly and antibiotic-steroid combination treatment in corneal ulcer patients: double-blinded randomized clinical trial. Canadian journal of ophthalmology Journal canadien d'ophtalmologie 2011; 46: 40-45
  30. Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Lalitha P, Glidden DV, Ray KJ, Hong KC, Oldenburg CE, Lee SM, Zegans ME, McLeod SD, Lietman TM, Acharya NR. Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT). Archives of ophthalmology (Chicago, Ill: 1960) 2012; 130: 143-150
  31. Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Lalitha P, Glidden DV, Ray KJ, Hong KC, Oldenburg CE, Lee SM, Zegans ME, McLeod SD, Lietman TM, Acharya NR. The steroids for corneal ulcers trial: study design and baseline characteristics. Archives of ophthalmology (Chicago, Ill: 1960) 2012; 130: 151-157
  32. Sy A, Srinivasan M, Mascarenhas J, Lalitha P, Rajaraman R, Ravindran M, Oldenburg CE, Ray KJ, Glidden D, Zegans ME, McLeod SD, Lietman TM, Acharya NR. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. Investigative ophthalmology & visual science 2012; 53: 267-272
  33. Holland EJ, Schwartz GS. Classification of herpes simplex virus keratitis. Cornea 1999; 18: 144-154
  34. Darougar S, Wishart MS, Viswalingam ND. Epidemiological and clinical features of primary herpes simplex virus ocular infection. The British journal of ophthalmology 1985; 69: 2-6
  35. Wilhelmus KR. Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis. The Cochrane database of systematic reviews 2015; 1: Cd002898
  36. Collum Lm Fau - Logan P, Logan P Fau - McAuliffe-Curtin D, McAuliffe- Curtin D Fau - Hung SO, Hung So Fau - Patterson A, Patterson A Fau - Rees PJ, Rees PJ. Randomised double-blind trial of acyclovir (Zovirax) and adenine arabinoside in herpes simplex amoeboid corneal ulceration.
  37. Polcicova K, Biswas PS, Banerjee K, Wisner TW, Rouse BT, Johnson DC. Herpes keratitis in the absence of anterograde transport of virus from sensory ganglia to the cornea. Proceedings of the National Academy of Sciences of the United States of America 2005; 102: 11462-11467
  38. Park PJ, Chang M, Garg N, Zhu J, Chang JH, Shukla D. Corneal lymphangiogenesis in herpetic stromal keratitis. Survey of ophthalmology 2015; 60: 60-71
  39. Kaye S, Choudhary A. Herpes simplex keratitis. Progress in retinal and eye research 2006; 25: 355-380
  40. Wickham S, Carr DJ. Molecular mimicry versus bystander activation: herpetic stromal keratitis. Autoimmunity 2004; 37: 393-397
  41. Wilhelmus KR, Gee L, Hauck WW, Kurinij N, Dawson CR, Jones DB, Barron BA, Kaufman HE, Sugar J, Hyndiuk RA, et al. Herpetic Eye Disease Study. A controlled trial of topical corticosteroids for herpes simplex stromal keratitis. Ophthalmology 1994; 101: 1883-1895; discussion 1895-1886
  42. Mitsui Y, Hanabusa J. Corneal infections after cortisone therapy. The British journal of ophthalmology 1955; 39: 244-250
  43. Wang T, Li S, Gao H, Shi W. Therapeutic dilemma in fungal keratitis: administration of steroids for immune rejection early after keratoplasty. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2016; 254: 1585-1589
  44. Zimmerman LE. Keratomycosis. Survey of ophthalmology 1963; 8: 1-25
  45. Pineda R, 2nd, Dohlman CH. The role of steroids in the management of Acanthamoeba keratitis, fungal keratitis, and epidemic keratoconjunctivitis. International ophthalmology clinics 1994; 34: 19-31
  46. Berson EL, Kobayashi GS, Becker B, Rosenbaum L. Topical corticosteroids and fungal keratitis. Investigative ophthalmology 1967; 6: 512- 517
  47. Burda CD, Fisher E, Jr. The use of cortisone in establishing experimental fungal keratitis in rats: a preliminary report. American journal of ophthalmology 1959; 48(3), Part 2: 330-335
  48. Forster RK, Rebell G. Animal model of Fusarium solani keratitis. American journal of ophthalmology 1975; 79: 510-515
  49. Francois J, Rijsselaere M. Corticosteroids and ocular mycoses: experimental study. Annals of ophthalmology 1974; 6: 207-217
  50. O'Day DM, Ray WA, Robinson R, Head WS. Efficacy of antifungal agents in the cornea. II. Influence of corticosteroids. Investigative ophthalmology & visual science 1984; 25: 331-335
  51. O'Day DM, Ray WA, Head WS, Robinson RD, Williams TE. Influence of corticosteroid on experimentally induced keratomycosis. Archives of ophthalmology (Chicago, Ill: 1960) 1991; 109: 1601-1604
  52. O'Day DM, Head WS, Robinson RD, Williams TE, Gedde S. The evaluation of therapeutic responses in experimental keratomycosis. Current eye research 1992; 11: 35-44
  53. Schreiber W, Olbrisch A, Vorwerk CK, Konig W, Behrens-Baumann W. Combined topical fluconazole and corticosteroid treatment for experimental Candida albicans keratomycosis. Investigative ophthalmology & visual science 2003; 44: 2634-2643
  54. Chew R, Dorman A, Woods ML. Purpureocillium lilacinum keratitis: a case series and review of the literature. Canadian journal of ophthalmology Journal canadien d'ophtalmologie 2016; 51: 382-385
  55. Ong HS, Fung SSM, Macleod D, Dart JKG, Tuft SJ, Burton MJ. Altered Patterns of Fungal Keratitis at a London Ophthalmic Referral Hospital: An Eight-Year Retrospective Observational Study. American journal of ophthalmology 2016; 168: 227-236
  56. Small KW, Chan CK, Silva-Garcia R, Walsh TJ. Onset of an outbreak of Bipolaris hawaiiensis fungal endophthalmitis after intravitreal injections of triamcinolone. Ophthalmology 2014; 121: 952-958
  57. Todokoro D, Hoshino J, Yo A, Makimura K, Hirato J, Akiyama H. Scedosporium apiospermum infectious scleritis following posterior subtenon triamcinolone acetonide injection: a case report and literature review. BMC ophthalmology 2018; 18: 40
  58. Vanzzini Zago V, Manzano-Gayosso P, Hernandez-Hernandez F, Mendez- Tovar LJ, Gomez-Leal A, Lopez Martinez R. [Mycotic keratitis in an eye care hospital in Mexico City]. Revista iberoamericana de micologia 2010; 27: 57-61
  59. Peponis V, Herz JB, Kaufman HE. The role of corticosteroids in fungal keratitis: a different view. The British journal of ophthalmology 2004; 88: 1227
  60. McClellan K, Howard K, Niederkorn JY, Alizadeh H. Effect of steroids on Acanthamoeba cysts and trophozoites. Investigative ophthalmology & visual science 2001; 42: 2885-2893
  61. Kaiserman I, Bahar I, McAllum P, Srinivasan S, Elbaz U, Slomovic AR, Rootman DS. Prognostic factors in Acanthamoeba keratitis. Canadian journal of ophthalmology Journal canadien d'ophtalmologie 2012; 47: 312-317
  62. Robaei D, Carnt N, Minassian DC, Dart JK. The impact of topical corticosteroid use before diagnosis on the outcome of Acanthamoeba keratitis. Ophthalmology 2014; 121: 1383-1388
  63. O'Day DM, Head WS. Advances in the management of keratomycosis and Acanthamoeba keratitis. Cornea 2000; 19: 681-687
  64. Rabinovitch T, Weissman SS, Ostler HB, Sheppard JD, Teikari J. Acanthamoeba keratitis: clinical signs and analysis of outcome. Reviews of infectious diseases 1991; 13. Suppl 5: S427
  65. Park DH, Palay DA, Daya SM, Stulting RD, Krachmer JH, Holland EJ. The role of topical corticosteroids in the management of Acanthamoeba keratitis. Cornea 1997; 16: 277-283
  66. Carnt N, Robaei D, Watson SL, Minassian DC, Dart JK. The Impact of Topical Corticosteroids Used in Conjunction with Antiamoebic Therapy on the Outcome of Acanthamoeba Keratitis. Ophthalmology 2016; 123: 984-990
  67. Iovieno A, Gore DM, Carnt N, Dart JK. Acanthamoeba sclerokeratitis: epidemiology, clinical features, and treatment outcomes. Ophthalmology 2014; 121: 2340-2347
  68. Lee GA, Gray TB, Dart JK, Pavesio CE, Ficker LA, Larkin DF, Matheson MM. Acanthamoeba sclerokeratitis: treatment with systemic immunosuppression. Ophthalmology 2002; 109: 1178-1182
  69. Chang JH, Gabison EE, Kato T, Azar DT. Corneal neovascularization. Current opinion in ophthalmology 2001; 12: 242-249
  70. Bacon AS, Frazer DG, Dart JK, Matheson M, Ficker LA, Wright P. A review of 72 consecutive cases of Acanthamoeba keratitis, 1984-1992. Eye (London, England) 1993; 7 (Pt 6): 719-725.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.